Hepatitis B virus and Hepatitis C Virus (HBV and HCV) are severe liver infection with potentially fatal consequences. It ranks as the 10th leading cause of mortality globally and is closely linked to the development of liver cirrhosis and hepatocellular carcinoma which could lead to liver failure. In Nigeria, according to statistics, Nasarawa State  and Kaduna state have shown to have more cases of Hepatitis B and Hepatitis C. 

To this effect, Everight Healthcare foundation with approval from the Nasarawa state commissioner of health, set out to have an outreach which spanned 3 phases at two primary healthcare centers, namely Mararaba Primary Healthcare Center and Masaka Primary Healthcare Center all located in Nasarawa State.

Phase 1 included the screening of participants living in these axis for hepatitis B and C and we vaccinated those found negative for hepatitis B. This was done on the 28th at the Mararaba Healthcare Center and on the 30th at the Masaka Healthcare center.

Phase 2 included those who received the first vaccination only and were given the second dose of the vaccine on the  and phase 3 will include those who were able to take the first and second vaccination only. This was to done in the months of September, October and November as this is the required standard.

Mararaba Analysis

 The total number of people screened at Mararaba was 549 with 339 being females and 210 were males. Of the 549, 484 people were found negative and all took the first dose of the Hep B vaccine. The Second vaccination was done on the 26th of October and only 254 of them were vaccinated. The third vaccination was done on the 23rd of November and 209 were vaccinated. This means 209 started and completed the vaccine.